Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00129363 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Safety of Twice Daily Oral Carvedilol
A Phase 3 study of Congestive Heart Failure, sponsored by Shaddy, Robert, M.D..
- Completed
- Registry status
- Phase 3
- Development phase
- 75
- Enrollment target
- 17
- Study locations
NCT00129363: Completed Phase 3 study of Congestive Heart Failure, sponsored by Shaddy, Robert, M.D..
NCT00129363 is a Phase 3 study of Congestive Heart Failure that has completed, run by Shaddy, Robert, M.D.. The registered enrollment target is 75 participants, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (77% lower). The trial reports 17 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00129363, a Phase 3 study of Congestive Heart Failure, has completed, sponsored by Shaddy, Robert, M.D..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 75 participants
- Enrollment target
- 17
- Study locations
Study Summary
The objective of this study is to evaluate the long-term safety of carvedilol in pediatric patients with chronic heart failure, who completed the Pediatric Carvedilol Study 321. Carvedilol will be provided as open-label therapy for a period of at least 6 months (or until termination of the study) by SmithKline Beecham Corporation d/b/a GlaxoSmithKline (GSK) or the University Sponsor.
Conditions Studied
Interventions
- DRUG Carvedilol
Study Locations (17)
California
- Mattel Children's Hospital at UCLA - Los Angeles
- Children's Hospital Los Angeles - Los Angeles
- Stanford University - Palo Alto
Michigan
- C.S. Mott Children's Hospital - Ann Arbor
- Children's Hospital of Michigan - Detroit
Texas
- UT Southwestern Medical Center - Dallas
- Texas Children's Hospital - Houston
Colorado
- University of Colorado - Denver
Florida
- University of Miami - Miami
Illinois
- Children's Memorial Hospital - Chicago
Massachusetts
- Children's Hospital, Boston - Boston
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2002-01 |
| Est. Completion | 2006-01 |
| Phase | Phase 3 |
What the finished NCT00129363 record still lists
NCT00129363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Carvedilol is the first listed.
NCT00129363 lists 17 locations in 13 states (California, Michigan, Texas).
Frequently Asked Questions
What is clinical trial NCT00129363 about?
NCT00129363 is a clinical study titled "Study to Evaluate the Safety of Twice Daily Oral Carvedilol". The objective of this study is to evaluate the long-term safety of carvedilol in pediatric patients with chronic heart failure, who completed the Pediatric Carvedilol Study 321. Carvedilol will be provided as open-label therapy for a period of at least 6 months (or until termination of the study) by...
What is the current status of trial NCT00129363?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2002-01. Estimated completion is 2006-01.
What conditions does trial NCT00129363 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT00129363?
The interventions under investigation include: Carvedilol (DRUG).
Who is sponsoring clinical trial NCT00129363?
This trial is sponsored by Shaddy, Robert, M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00129363 being conducted?
This trial has 17 study locations across California, Colorado, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00129363's enrollment target sits among peer trials
75 31st of 51 higher than 21 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
COMPLETED · Phase 3
-
DILIPO (DILutIonal HyPOnatremia)
COMPLETED · Phase 3
-
Palliative Care for People With HF
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia